Artificial Saliva Containing Cumin and Ginger Extract in Hemodialysis Patients With Xerostomia

ConditionXerostomia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChulalongkorn University

About this trial

Hemodialysis patients with xerostomia are divided into 2 groups which are group A (start with artificial saliva containing cumin and ginger extract for 2 weeks, free periods 2 weeks, then placebo for 2 weeks) and group B (start with placebo for 2 weeks, free periods 2 weeks, then artificial saliva containing cumin and ginger extract for 2 weeks). Amount of saliva (g/min), xerostomia's questionnaire, Increase of saliva score, World Health Organization Oral Mucositis Grading Scale, acid and base of saliva, quality of life's questionnaire will measure before, after using the sample for 7 and 14 days.

Eligibility criteria

Qualifiers

Age more than 18 years

Hemodialysis patients with xerostomia (saliva flow rate less than 0.2 g/min)

Hemodialysed history more than 3 months

Be willing to participate in the study

Disqualifiers

Patients with sialolith or Sjogren's syndrome

Uncontrolled other diseases

Using artificial saliva for more than 2 weeks

Taking pilocarpine and cevimeline

Trial design

Treatments tested in this trial

  • Artificial saliva containing cumin and ginger extract
  • Placebo

Treatment groups

26 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators